DEF 14A: Rafael Holdings Sets Annual Meeting for January 9, 2025, Proposes Director Elections and Equity Plan Amendment

Rafael Holdings has announced its annual meeting of stockholders to be held on January 9, 2025, where shareholders will vote on the election of directors, the ratification of the company's accounting firm, and an amendment to the equity incentive plan.

Summary

• Rafael Holdings will hold its annual meeting of stockholders on January 9, 2025, at 11:30 a.m. local time, at its offices in Newark, New Jersey.
• Stockholders of record as of November 12, 2024, are eligible to vote at the meeting.
• The meeting will include voting on the election of five directors, the ratification of CohnReznick LLP as the company's independent accounting firm for the fiscal year ending July 31, 2025, and an amendment to the 2021 Equity Incentive Plan to increase the number of shares available by 750,000.
• The company is soliciting proxies by mail and email, and will bear all costs associated with the solicitation.
• As of the record date, Rafael Holdings had 24,674,150 shares outstanding, consisting of 787,163 Class A shares and 23,886,987 Class B shares.
• Class A shares have three votes each, while Class B shares have one-tenth of one vote each.
• A majority of the voting power is required for a quorum, and a majority of votes cast is required for the approval of each proposal.
• The company's fiscal year ends on July 31.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company is adhering to corporate governance standards and seeking to incentivize its personnel, the significant net losses and declining stock price raise concerns. The related party transactions also add a layer of complexity that requires careful consideration.

Positives

• The company has a comprehensive corporate governance framework in place.
• A majority of the board members are independent, despite the company being a controlled entity.
• The company has adopted a clawback policy for executive compensation.
• The company is not relying on exemptions available to controlled companies from NYSE corporate governance listing requirements.
• The company has a policy in place for reviewing related person transactions.

Negatives

• The company's net loss for fiscal year 2024 was $65,003,000.
• The company has significant related party transactions, including services provided by IDT Corporation, which is controlled by the same individual.
• The company has a history of significant losses, with a net loss of $142,377,000 in fiscal year 2022.
• The company's stock price has decreased significantly since 2021, with a hypothetical $100 investment in 2021 being worth $2.94 in 2024.

Risks

• The company's financial performance is heavily influenced by the market price of its Class B Common Stock, which has been volatile.
• The company has significant related party transactions, which could pose a conflict of interest.
• The company's executive compensation is not directly correlated with net income or total shareholder return.
• The company's reliance on a single individual, Howard S. Jonas, for control and leadership poses a key person risk.
• The company's ability to attract and retain key employees, directors, and consultants depends on the availability of shares under the equity incentive plan.

Future Outlook

The document does not contain specific forward-looking statements or guidance, but it does propose an increase in the number of shares available under the equity incentive plan, which suggests the company anticipates future grants to attract and retain key personnel.

Management Comments

• The Compensation Committee believes that our non-employee director compensation is fair and appropriate in light of the responsibilities and obligations of our non-employee directors.
• The Board of Directors believes that the proposed amendment to increase the number of shares of Class B Common Stock available for the grant of awards thereunder by 750,000 is necessary in order to provide the Company with a sufficient reserve of shares of Class B Common Stock for future grants needed to attract and retain the services of key employees, directors and consultants of the Company essential to the Companys long-term success.

Industry Context

This announcement is typical for a publicly traded company, outlining the agenda for its annual meeting and seeking shareholder approval for key governance and compensation matters. The proposed increase in the equity incentive plan is a common practice to align management and employee interests with those of shareholders.

Comparison to Industry Standards

• The company's corporate governance practices, such as having a majority of independent directors and a clawback policy, are in line with industry standards for publicly traded companies.
• The company's related party transactions, particularly with IDT Corporation, are not uncommon but require careful scrutiny to ensure they are conducted at arm's length and in the best interests of the company and its shareholders.
• The company's executive compensation structure, including base salary, bonuses, and equity awards, is similar to that of other companies in the pharmaceutical and biotech industries.
• The company's net losses and declining stock price are concerning and may indicate underperformance compared to industry benchmarks.
• The company's non-employee director compensation is capped at $750,000 per fiscal year, which is within the range of what is seen in similar companies.

Management Changes

Corporate Governance

Related Party Transactions

• IDT Corporation, for which Howard Jonas serves as Chairman of the Board, provides services to the Company under a Transition Services Agreement, billing $296,232 in Fiscal 2024.
• IDT leased space from the Company in Jerusalem, Israel, paying $0 in rent during Fiscal 2024, and owing $331,861 as of July 31, 2024.
• The Company owns 67% of Cornerstone Pharmaceuticals, Inc., and has transactions with them, including billing $190,800 for services in Fiscal 2024 and being owed $910,800 as of July 31, 2024.
• The Company paid Sam Beyda, Howard Jonas' son-in-law, a salary of $160,132 in Fiscal 2024.

Stakeholder Impact

• Shareholders will vote on key governance and compensation matters, including the election of directors and the equity incentive plan amendment.
• Employees may be impacted by changes to the equity incentive plan, which could affect their compensation.
• The company's financial performance and stock price will impact shareholder value.
• The company's related party transactions may raise concerns among stakeholders about potential conflicts of interest.

Next Steps

• Stockholders are urged to vote on the proposals outlined in the proxy statement.
• The company will hold its annual meeting on January 9, 2025.
• The company will continue to operate under its existing corporate governance framework.
• The company will continue to evaluate its executive compensation practices.

Key Dates

Keywords

Annual Meeting, Proxy Statement, Director Election, Equity Incentive Plan, CohnReznick LLP, Corporate Governance, Related Party Transactions, Executive Compensation, Stockholders, Board of Directors